Estradiol has been postulated to constitute a protective factor for schizop
hrenia, which could provide women at risk to experience a psychotic episode
with a relative protection in phases of high estradiol levels, i.e. before
menopause and during the peri- and postovulatory phases of their cycle. Wo
men suffering from schizophrenia have been reported to show significantly l
ower estradiol levels than the normal population and to experience first on
set or recurrence of a psychotic episode significantly more often in low es
trogen phases of the cycle with low estradiol levels. We examined estradiol
levels in an open prospective study in 43 women admitted with a diagnosis
of an acute psychotic episode and could confirm these findings for schizoph
renia as well as other psychotic disorders. Only 28% of the women exhibited
estradiol and progesterone levels indicating a peri- or postovulatory phas
e and all of the estradiol levels on admission were either within the lower
part of the cycle-dependent normal range or below normal; comparison with
a control group of healthy volunteers and patients admitted with different
psychiatric diagnoses confirmed their estradiol levels to be significantly
higher. However, when splitting this control group, the statistical differe
nce would only hold between the study group of psychotic patients and the h
ealthy control group. The group of patients with other diagnoses than a psy
chotic episode fell in between of the other two groups and did not differ s
ignificantly from either. Thus, an unspecific effect, i.e. a hypothalamic d
ownregulation due to the stress of acute hospitalization must be born in mi
nd when assessing hormone levels in acutely psychotic women. (C) 2000 Elsev
ier Science Ltd. All rights reserved.